David Roman
Stock Analyst at Goldman Sachs
(1.79)
# 3,346
Out of 5,132 analysts
63
Total ratings
33.33%
Success rate
-6.21%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Buy | $108 → $95 | $75.87 | +25.21% | 5 | Feb 11, 2026 | |
| DOCS Doximity | Maintains: Neutral | $46 → $34 | $25.02 | +35.89% | 5 | Feb 9, 2026 | |
| MDLN Medline | Initiates: Buy | $49 | $44.55 | +9.99% | 1 | Jan 12, 2026 | |
| HQY HealthEquity | Downgrades: Sell | $89 | $73.88 | +20.47% | 4 | Jan 9, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $22 → $25 | $26.92 | -7.13% | 3 | Dec 15, 2025 | |
| COO The Cooper Companies | Maintains: Sell | $64 → $71 | $82.99 | -14.45% | 2 | Dec 8, 2025 | |
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $99.49 | +11.57% | 2 | Nov 19, 2025 | |
| IRTC iRhythm Holdings | Maintains: Neutral | $180 → $202 | $144.30 | +39.99% | 4 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $25 → $22 | $19.79 | +11.17% | 4 | Oct 31, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $26 → $33 | $13.94 | +136.73% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $16 | $17.03 | -6.05% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $103 | $109.47 | -5.91% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $13.06 | +53.14% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $10.95 | +73.52% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $11.31 | +156.41% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $242.74 | +56.55% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $96.45 | +7.83% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $4.65 | +115.05% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $80.34 | +2.07% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $112.68 | +36.67% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $18.96 | +26.58% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $75.55 | -6.02% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $65.82 | -16.44% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $366.05 | +16.65% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $74.73 | +20.43% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $485.84 | +2.91% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $175.89 | +55.78% | 1 | May 30, 2024 |
Edwards Lifesciences
Feb 11, 2026
Maintains: Buy
Price Target: $108 → $95
Current: $75.87
Upside: +25.21%
Doximity
Feb 9, 2026
Maintains: Neutral
Price Target: $46 → $34
Current: $25.02
Upside: +35.89%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $49
Current: $44.55
Upside: +9.99%
HealthEquity
Jan 9, 2026
Downgrades: Sell
Price Target: $89
Current: $73.88
Upside: +20.47%
Kestra Medical Technologies
Dec 15, 2025
Maintains: Neutral
Price Target: $22 → $25
Current: $26.92
Upside: -7.13%
The Cooper Companies
Dec 8, 2025
Maintains: Sell
Price Target: $64 → $71
Current: $82.99
Upside: -14.45%
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $99.49
Upside: +11.57%
iRhythm Holdings
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $144.30
Upside: +39.99%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $25 → $22
Current: $19.79
Upside: +11.17%
Beta Bionics
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $13.94
Upside: +136.73%
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $17.03
Upside: -6.05%
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $109.47
Upside: -5.91%
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $13.06
Upside: +53.14%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $10.95
Upside: +73.52%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $11.31
Upside: +156.41%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $242.74
Upside: +56.55%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $96.45
Upside: +7.83%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $4.65
Upside: +115.05%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $80.34
Upside: +2.07%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $112.68
Upside: +36.67%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $18.96
Upside: +26.58%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $75.55
Upside: -6.02%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $65.82
Upside: -16.44%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $366.05
Upside: +16.65%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $74.73
Upside: +20.43%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $485.84
Upside: +2.91%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $175.89
Upside: +55.78%